Howard G C, Clarke K, Elia M H, Hutcheon A W, Kaye S B, Windsor P M, Yosef H M, Sharp L
Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.
Br J Cancer. 1995 Nov;72(5):1307-11. doi: 10.1038/bjc.1995.506.
A detailed casenote review was performed on 55 patients registered with testicular non-seminomatous germ cell tumours (NSGCT) between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992. Details of all aspects of clinical management relating to their NSGCT and death details were extracted and summarised. An assessment was made on whether the patients' management had been optimal. An analysis of 5 year survival rates by the five Scottish oncology centres demonstrated significant differences between centres (range 70.4-94.2; chi 2 = 14.46, d.f. = 4, P = 0.006). Some patients in all centres were assessed as having received suboptimal treatment, but two centres performed less well than the other three. There is a suggestion that the number of patients treated suboptimally decreases with increasing number of patients seen, but this does not reach statistical significance.
对1983年至1988年间在苏格兰癌症登记计划下登记患有睾丸非精原细胞瘤（NSGCT）且于1992年前死亡的55名患者进行了详细的病例记录回顾。提取并总结了与他们的NSGCT相关的临床管理各方面细节以及死亡细节。评估了患者的治疗是否达到最佳。对五个苏格兰肿瘤中心的5年生存率进行分析，结果显示各中心之间存在显著差异（范围为70.4 - 94.2；卡方 = 14.46，自由度 = 4，P = 0.006）。所有中心都有一些患者被评估为接受了次优治疗，但有两个中心的表现不如其他三个中心。有迹象表明，接受次优治疗的患者数量随着就诊患者数量的增加而减少，但这未达到统计学意义。
